PLIANT THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
PLIANT THERAPEUTICS, INC. (PLRX) reported Increase Decrease In Operating Lease Liability of -$362.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$42.00K, a 133.33% decline year-over-year.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$320.00K.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$313.00K.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$598.00K.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$876.00K.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$820.00K.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$2.75M.
- PLIANT THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$2.26M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$362.00K 10-Q · filed 2026-08-11 | -$675.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$320.00K 10-Q · filed 2026-05-11 | -$633.00K derived: sum of 2 quarters · filed 2026-05-11 | -$1.23M derived: sum of 3 quarters · filed 2026-05-11 | -$1.10M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$911.00K derived: sum of 2 quarters · filed 2026-03-11 | -$785.00K derived: sum of 3 quarters · filed 2026-08-11 | -$876.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$598.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$472.00K derived: sum of 2 quarters · filed 2026-08-11 | -$563.00K 10-Q · filed 2025-11-06 | -$656.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $35.00K 10-Q · filed 2026-08-11 | -$58.00K derived: sum of 3 quarters · filed 2026-08-11 | -$140.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$91.00K 10-Q · filed 2026-05-11 | -$184.00K derived: sum of 2 quarters · filed 2026-05-11 | -$266.00K derived: sum of 3 quarters · filed 2026-05-11 | -$548.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$175.00K derived: sum of 2 quarters · filed 2026-03-11 | -$457.00K derived: sum of 3 quarters · filed 2026-03-11 | -$820.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$364.00K derived: sum of 2 quarters · filed 2025-11-06 | -$727.00K 10-Q · filed 2025-11-06 | -$1.47M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$282.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$645.00K 10-Q · filed 2025-08-07 | -$1.39M derived: sum of 3 quarters · filed 2025-08-07 | -$2.06M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$363.00K 10-Q · filed 2025-05-08 | -$1.11M derived: sum of 2 quarters · filed 2025-05-08 | -$1.77M derived: sum of 3 quarters · filed 2025-05-08 | -$2.45M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.41M derived: sum of 2 quarters · filed 2025-03-03 | -$2.09M derived: sum of 3 quarters · filed 2025-03-03 | -$2.75M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.35M derived: sum of 2 quarters · filed 2024-11-07 | -$2.00M 10-Q · filed 2024-11-07 | -$2.89M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$680.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.34M 10-Q · filed 2024-08-07 | -$2.23M derived: sum of 3 quarters · filed 2025-03-03 | -$2.85M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$656.00K 10-Q · filed 2024-05-06 | -$1.54M derived: sum of 2 quarters · filed 2025-03-03 | -$2.17M derived: sum of 3 quarters · filed 2025-03-03 | -$2.64M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.51M derived: sum of 2 quarters · filed 2025-03-03 | -$1.98M derived: sum of 3 quarters · filed 2025-03-03 | -$2.26M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$624.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.09M derived: sum of 2 quarters · filed 2023-11-09 | -$1.37M 10-Q · filed 2023-11-09 | -$2.21M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$745.00K 10-Q · filed 2023-08-09 | -$1.58M derived: sum of 3 quarters · filed 2024-02-27 | -$2.03M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$275.00K 10-Q · filed 2023-05-09 | -$1.11M derived: sum of 2 quarters · filed 2024-02-27 | -$1.56M derived: sum of 3 quarters · filed 2024-02-27 | -$1.67M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.29M derived: sum of 2 quarters · filed 2024-02-27 | -$1.39M derived: sum of 3 quarters · filed 2024-02-27 | -$1.75M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$557.00K derived: sum of 2 quarters · filed 2022-11-08 | -$918.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$467.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$361.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |